OnKure Therapeutics (OKUR) Financials: Revenue & Earnings
OKUR$2.52-0.07 -2.89%
$102.05M
Market Cap
—
P/E
—
Forward P/E
—
Score
OnKure Therapeutics (OKUR) Financials: Revenue & Earnings
OKUR price $2.52 -0.07 -2.89%
- Ticker
- OKUR
- Price
- $2.52
- Change
- -0.07 -2.89%
- Market cap ?
- $102.05M
- Beta ?
- 0.30
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
OKUR fair value Not meaningful. Price $2.52.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | -0.41 | — | 166.67K |
| 2026-08-04 | -0.31 | -0.54 | — | 166.67K |
| 2026-05-05 | -1.11 | -0.81 | — | 166.67K |
| 2026-03-12 | -0.99 | -1.15 | — | 15.96M |
| 2025-11-06 | -1.09 | -1.20 | — | — |
| 2025-08-12 | -1.14 | -1.23 | — | — |
| 2025-05-06 | -1.19 | -1.32 | — | — |
| 2025-03-10 | -1.37 | -0.86 | — | — |
| 2024-11-07 | -1.10 | -0.97 | — | — |
| 2024-08-13 | -1.60 | -1.00 | — | — |
| 2024-05-07 | -2.50 | -4.37 | — | — |
| 2024-03-28 | -7.00 | -5.78 | — | — |
| 2023-11-13 | -5.70 | -5.71 | — | — |
| 2023-08-10 | -6.50 | -5.30 | — | — |
| 2023-05-11 | -6.00 | -6.04 | — | — |
| 2023-03-27 | -5.60 | -5.88 | — | — |
| 2022-11-08 | -5.30 | -5.72 | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-21 | Saccomano Nicholas A | Sell | 87 | $2.97 | 259 |
| 2026-09-21 | Leverone Jason A. | Sell | 302 | $2.97 | 898 |
| 2026-08-07 | Manke Isaac | Other | 0 | — | — |
| 2026-08-07 | Mathers Edward T | Buy | 22.35K | $4.14 | 92.53K |
| 2026-08-07 | Ratcliffe Liam | Buy | 22.35K | $4.14 | 92.53K |
| 2026-08-07 | Phillips Andrew John | Buy | 22.35K | $4.14 | 92.53K |
| 2026-08-07 | Manke Isaac | Buy | 300.00K | $4.14 | 1.24M |
| 2026-08-07 | Manke Isaac | Buy | 15.30K | $4.14 | 63.34K |
| 2026-08-07 | Manke Isaac | Sell | 15.30K | $18.20 | 278.46K |
| 2026-08-07 | Jansen Valerie Malyvanh | Buy | 22.35K | $4.14 | 92.53K |
| 2026-08-07 | GREY MICHAEL G | Buy | 22.35K | $4.14 | 92.53K |
| 2026-08-07 | Carruthers R Michael | Buy | 22.35K | $4.14 | 92.53K |
| 2026-08-07 | Saccomano Nicholas A | Buy | 542.23K | $4.14 | 2.24M |
| 2026-08-07 | Saccomano Nicholas A | Buy | 150.00K | $4.14 | 621.00K |
| 2026-08-07 | Saccomano Nicholas A | Buy | 16.90K | $4.14 | 69.96K |
| 2026-08-07 | Saccomano Nicholas A | Buy | 8.45K | $4.14 | 34.98K |
| 2026-08-07 | Saccomano Nicholas A | Buy | 2.36K | $4.14 | 9.77K |
| 2026-08-07 | Saccomano Nicholas A | Buy | 1.49K | $4.14 | 6.15K |
| 2026-08-07 | Saccomano Nicholas A | Sell | 16.90K | $13.99 | 236.40K |
| 2026-08-07 | Saccomano Nicholas A | Sell | 542.23K | $18.20 | 9.87M |
| 2026-08-07 | Saccomano Nicholas A | Sell | 2.36K | $21.20 | 50.01K |
| 2026-08-07 | Leverone Jason A. | Buy | 130.61K | $4.14 | 540.73K |
| 2026-08-07 | Leverone Jason A. | Buy | 50.00K | $4.14 | 207.00K |
| 2026-08-07 | Leverone Jason A. | Buy | 5.78K | $4.14 | 23.93K |
| 2026-08-07 | Leverone Jason A. | Buy | 5.32K | $4.14 | 22.03K |
| 2026-08-07 | Leverone Jason A. | Sell | 5.32K | $13.99 | 74.45K |
| 2026-08-07 | Leverone Jason A. | Sell | 130.61K | $18.20 | 2.38M |
| 2026-08-07 | Leverone Jason A. | Sell | 5.78K | $21.20 | 122.56K |
| 2026-08-07 | Hartley Dylan | Buy | 137.60K | $4.14 | 569.68K |
| 2026-08-07 | Hartley Dylan | Buy | 50.00K | $4.14 | 207.00K |
| 2026-08-07 | Hartley Dylan | Sell | 137.60K | $18.20 | 2.50M |
| 2026-08-07 | Agresta Samuel | Buy | 131.40K | $4.14 | 543.98K |
| 2026-08-07 | Agresta Samuel | Buy | 50.00K | $4.14 | 207.00K |
| 2026-08-07 | Agresta Samuel | Buy | 18.59K | $4.14 | 76.95K |
| 2026-08-07 | Agresta Samuel | Sell | 18.59K | $13.99 | 260.05K |
| 2026-08-07 | Agresta Samuel | Sell | 131.40K | $18.20 | 2.39M |
| 2026-06-22 | Saccomano Nicholas A | Sell | 86 | $4.40 | 378 |
| 2026-06-22 | Leverone Jason A. | Sell | 303 | $4.40 | 1.33K |
| 2026-06-04 | Mathers Edward T | Buy | 7.65K | $4.30 | 32.90K |
| 2026-06-04 | Ratcliffe Liam | Buy | 1.27K | $4.30 | 5.48K |
| 2026-06-04 | Phillips Andrew John | Buy | 7.65K | $4.30 | 32.90K |
| 2026-06-04 | Jansen Valerie Malyvanh | Buy | 7.65K | $4.30 | 32.90K |
| 2026-06-04 | GREY MICHAEL G | Buy | 7.65K | $4.30 | 32.90K |
| 2026-06-04 | Carruthers R Michael | Buy | 7.65K | $4.30 | 32.90K |
| 2026-04-01 | Saccomano Nicholas A | Buy | 330.00K | $4.07 | 1.34M |
| 2026-04-01 | Leverone Jason A. | Buy | 110.00K | $4.07 | 447.70K |
| 2026-04-01 | Hartley Dylan | Buy | 110.00K | $4.07 | 447.70K |
| 2026-04-01 | Agresta Samuel | Buy | 110.00K | $4.07 | 447.70K |
| 2026-03-31 | AI Biotechnology LLC | Other | 0 | — | — |
| 2026-03-31 | AI Biotechnology LLC | Other | 5.64M | $0.00 | 564 |
| 2026-03-31 | Ratcliffe Liam | Buy | 15.30K | $4.14 | 63.34K |
| 2026-03-31 | Ratcliffe Liam | Other | 0 | — | — |
| 2026-03-23 | Saccomano Nicholas A | Sell | 86 | $4.16 | 357 |
| 2026-03-23 | Leverone Jason A. | Sell | 301 | $4.16 | 1.25K |
| 2025-12-31 | Mathers Edward T | Buy | 3.91K | — | — |
| 2025-12-31 | Manke Isaac | Buy | 5.26K | — | — |
| 2025-12-22 | Saccomano Nicholas A | Sell | 87 | $2.97 | 258 |
| 2025-12-22 | Leverone Jason A. | Sell | 302 | $2.97 | 896 |
| 2025-09-30 | Mathers Edward T | Buy | 4.12K | — | — |
| 2025-09-30 | Manke Isaac | Buy | 5.54K | — | — |
| 2025-09-22 | Saccomano Nicholas A | Sell | 88 | $2.62 | 231 |
| 2025-09-22 | Leverone Jason A. | Sell | 303 | $2.62 | 795 |
| 2025-06-30 | Mathers Edward T | Buy | 4.69K | — | — |
| 2025-06-30 | Manke Isaac | Buy | 6.31K | — | — |
| 2025-06-23 | Saccomano Nicholas A | Sell | 88 | $2.38 | 210 |
| 2025-06-23 | Leverone Jason A. | Sell | 303 | $2.38 | 722 |
| 2025-05-28 | Mathers Edward T | Buy | 7.65K | $2.44 | 18.67K |
| 2025-05-28 | Phillips Andrew John | Buy | 7.65K | $2.44 | 18.67K |
| 2025-05-28 | Manke Isaac | Buy | 7.65K | $2.44 | 18.67K |
| 2025-05-28 | Jansen Valerie Malyvanh | Buy | 7.65K | $2.44 | 18.67K |
| 2025-05-28 | GREY MICHAEL G | Buy | 7.65K | $2.44 | 18.67K |
| 2025-05-28 | Carruthers R Michael | Buy | 7.65K | $2.44 | 18.67K |
| 2025-05-15 | ACORN BIOVENTURES 2, L.P. | Other | 0 | — | — |
| 2025-05-15 | Cormorant Asset Management, LP | Sell | 1.81M | $1.85 | 3.36M |
| 2025-05-15 | ACORN BIOVENTURES, L.P. | Buy | 270.27K | $1.85 | 500.00K |
| 2025-05-15 | ACORN BIOVENTURES, L.P. | Buy | 1.13M | $1.85 | 2.09M |
| 2025-05-12 | Cormorant Asset Management, LP | Sell | 24.30K | $1.99 | 48.24K |
| 2025-04-07 | Saccomano Nicholas A | Sell | 516 | $2.67 | 1.38K |
| 2025-04-07 | Leverone Jason A. | Sell | 1.84K | $2.67 | 4.93K |
| 2025-04-04 | Saccomano Nicholas A | Sell | 358 | $3.33 | 1.19K |
| 2025-04-04 | Leverone Jason A. | Sell | 1.28K | $3.33 | 4.25K |
| 2025-03-31 | Mathers Edward T | Buy | 2.58K | — | — |
| 2025-03-31 | Manke Isaac | Buy | 3.47K | — | — |
| 2025-01-27 | Saccomano Nicholas A | Buy | 130.00K | $5.19 | 674.70K |
| 2025-01-27 | Leverone Jason A. | Buy | 65.00K | $5.19 | 337.35K |
| 2025-01-27 | Hartley Dylan | Buy | 45.00K | $5.19 | 233.55K |
| 2025-01-27 | Agresta Samuel | Buy | 45.00K | $5.19 | 233.55K |
| 2024-10-07 | Leonard Braden Michael | Buy | 345.74K | — | — |
| 2024-10-07 | Leonard Braden Michael | Buy | 102.08K | — | — |
| 2024-10-04 | Cormorant Asset Management, LP | Other | 0 | — | — |
| 2024-10-04 | ACORN BIOVENTURES, L.P. | Other | 0 | — | — |
| 2024-10-04 | Saccomano Nicholas A | Buy | 542.23K | $18.20 | 9.87M |
| 2024-10-04 | Saccomano Nicholas A | Buy | 16.90K | $13.99 | 236.40K |
| 2024-10-04 | Saccomano Nicholas A | Buy | 8.45K | $13.99 | 118.20K |
| 2024-10-04 | Saccomano Nicholas A | Buy | 4.56K | — | — |
| 2024-10-04 | Saccomano Nicholas A | Buy | 2.36K | $21.20 | 50.01K |
| 2024-10-04 | Saccomano Nicholas A | Buy | 1.49K | $13.99 | 20.78K |
| 2024-10-04 | Phillips Andrew John | Buy | 15.30K | $18.20 | 278.46K |
| 2024-10-04 | Mathers Edward T | Buy | 15.30K | $18.20 | 278.46K |
| 2024-10-04 | Manke Isaac | Buy | 15.30K | $18.20 | 278.46K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 76, holders +25 vs prior quarter. Ownership 70.04%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 4.00M | 0 | 0.00% | 18.23M |
| BVF INC/IL | 3.24M | 1.26M | +63.51% | 14.76M |
| ACORN CAPITAL ADVISORS, LLC | 2.84M | 0 | 0.00% | 12.95M |
| STEPSTONE GROUP LP | 2.66M | 0 | 0.00% | 12.13M |
| ADAR1 CAPITAL MANAGEMENT, LLC | 2.24M | -196.26K | -8.06% | 10.21M |
| VIVO CAPITAL, LLC | 1.93M | 0 | 0.00% | 8.79M |
| VESTAL POINT CAPITAL, LP | 1.83M | -14.12K | -0.77% | 8.33M |
| BLACKROCK, INC. | 1.50M | 1.45M | +2924.67% | 6.84M |
| TRAILS EDGE CAPITAL PARTNERS, LP | 1.44M | 1.44M | New | 6.56M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.44M | 854.56K | +146.71% | 6.55M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.20M | 0 | 0.00% | 5.49M |
| CITADEL ADVISORS LLC | 1.19M | 1.15M | +3058.13% | 5.41M |
| SIO CAPITAL MANAGEMENT, LLC | 1.08M | 0 | 0.00% | 4.92M |
| PROSIGHT MANAGEMENT, LP | 978.99K | -1.18M | -54.56% | 4.46M |
| LOGOS GLOBAL MANAGEMENT LP | 963.86K | 963.86K | New | 4.40M |
| GEODE CAPITAL MANAGEMENT, LLC | 724.44K | 625.69K | +633.61% | 3.30M |
| NEA MANAGEMENT COMPANY, LLC | 478.55K | 0 | 0.00% | 2.18M |
| STATE STREET CORP | 463.66K | 450.20K | +3344.23% | 2.11M |
| ENSIGN PEAK ADVISORS, INC | 431.63K | 431.63K | New | 1.97M |
| RENAISSANCE TECHNOLOGIES LLC | 358.74K | -18.51K | -4.91% | 1.64M |
| SOFINNOVA INVESTMENTS, INC. | 321.69K | 179.99K | +127.02% | 1.47M |
| CARLYLE GROUP INC. | 269.89K | 0 | 0.00% | 1.23M |
| AFFINITY ASSET ADVISORS, LLC | 240.96K | 0 | 0.00% | 1.10M |
| DV EQUITIES, LLC | 240.96K | 240.96K | New | 1.10M |
| SEVEN FLEET CAPITAL MANAGEMENT LP | 240.96K | 240.96K | New | 1.10M |
Earnings and financials
OnKure Therapeutics, Inc. (OKUR) trades at $2.52, with a market cap of $102.05M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn